114 related articles for article (PubMed ID: 8797919)
1. Asymmetric signal intensity of the renal collecting systems as a sign of unilateral renal artery stenosis following administration of gadopentetate dimeglumine.
Walsh P; Rofsky NM; Krinsky GA; Weinreb JC
J Comput Assist Tomogr; 1996; 20(5):812-4. PubMed ID: 8797919
[No Abstract] [Full Text] [Related]
2. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
[TBL] [Abstract][Full Text] [Related]
3. Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography.
Matchett WJ; McFarland DR; Russell DK; Sailors DM; Moursi MM
Radiology; 1996 Nov; 201(2):569-71. PubMed ID: 8888260
[TBL] [Abstract][Full Text] [Related]
4. T2*-weighted dynamic MR imaging in renal artery or vein stenosis.
Tsushima Y; Murakami T; Kuruma H; Kondo T; Kusano S
AJR Am J Roentgenol; 1997 Apr; 168(4):1041-3. PubMed ID: 9124111
[No Abstract] [Full Text] [Related]
5. Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures.
Kaufman JA; Geller SC; Waltman AC
Radiology; 1996 Feb; 198(2):579-81. PubMed ID: 8596869
[TBL] [Abstract][Full Text] [Related]
6. Fatal reaction to gadopentetate dimeglumine.
Jordan RM; Mintz RD
AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
[No Abstract] [Full Text] [Related]
7. Magnetization transfer contrast in gadopentetate-dimeglumine-enhanced breast magnetic resonance imaging at 0.1 Tesla.
Dean KI; Komu M; Dean PB; Kormano M
Invest Radiol; 1994 Jun; 29 Suppl 2():S302-3. PubMed ID: 7928264
[No Abstract] [Full Text] [Related]
8. Evaluation of renal artery stenosis with dynamic gadolinium-enhanced MR angiography.
Rieumont MJ; Kaufman JA; Geller SC; Yucel EK; Cambria RP; Fang LS; Bazari H; Waltman AC
AJR Am J Roentgenol; 1997 Jul; 169(1):39-44. PubMed ID: 9207498
[TBL] [Abstract][Full Text] [Related]
9. Suppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine.
Rofsky NM; Purdy DE; Johnson G; DeCorato DR; Earls JP; Krinsky G; Weinreb JC
Radiology; 1997 Jan; 202(1):177-82. PubMed ID: 8988209
[TBL] [Abstract][Full Text] [Related]
10. Gadopentetate dimeglumine-enhanced MR imaging of subdural hematoma in an abused infant.
Kleinman PK; Ragland RL
AJR Am J Roentgenol; 1996 Jun; 166(6):1456-8. PubMed ID: 8633463
[No Abstract] [Full Text] [Related]
11. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
[No Abstract] [Full Text] [Related]
12. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses.
Völk M; Strotzer M; Lenhart M; Seitz J; Manke C; Feuerbach S; Link J
Radiology; 2001 Aug; 220(2):484-8. PubMed ID: 11477257
[TBL] [Abstract][Full Text] [Related]
13. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
14. Gadopentetate-dimeglumine-enhanced magnetic resonance imaging for lung nodules. Differentiation of lung cancer and tuberculoma.
Kusumoto M; Kono M; Adachi S; Yamasaki K; Itouji E; Sakai E; Endo M; Nakamura T; Kimura K
Invest Radiol; 1994 Jun; 29 Suppl 2():S255-6. PubMed ID: 7928249
[No Abstract] [Full Text] [Related]
15. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
16. Is there any role for gadopentetate dimeglumine administration when searching for mesial temporal sclerosis in patients with seizures?
Bronen RA
AJR Am J Roentgenol; 1995 Feb; 164(2):503. PubMed ID: 7839999
[No Abstract] [Full Text] [Related]
17. Eye and testicular pain after administration of gadopentetate dimeglumine.
Padhani AR; Lopez AJ; Revell PB; MacVicar DA
AJR Am J Roentgenol; 1995 Aug; 165(2):484-5. PubMed ID: 7618587
[No Abstract] [Full Text] [Related]
18. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
19. Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications.
Niendorf HP; Alhassan A; Geens VR; Clauss W
Invest Radiol; 1994 Jun; 29 Suppl 2():S179-82. PubMed ID: 7928222
[No Abstract] [Full Text] [Related]
20. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches.
Prince MR; Narasimham DL; Stanley JC; Chenevert TL; Williams DM; Marx MV; Cho KJ
Radiology; 1995 Dec; 197(3):785-92. PubMed ID: 7480757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
